Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers:
SEC Accession No. 0001193125-25-314755
Filing Date
2025-12-11
Accepted
2025-12-10 21:54:10
Documents
21
Effectiveness Date
2025-12-11

Document Format Files

Seq Description Document Type Size
1 S-3ASR d16145ds3asr.htm S-3ASR 299628
2 EX-1.2 d16145dex12.htm EX-1.2 198790
3 EX-4.2 d16145dex42.htm EX-4.2 370397
4 EX-5.1 d16145dex51.htm EX-5.1 28021
5 EX-5.2 d16145dex52.htm EX-5.2 5877
6 EX-23.1 d16145dex231.htm EX-23.1 1392
7 EX-23.2 d16145dex232.htm EX-23.2 1905
8 EX-FILING FEES d16145dexfilingfees.htm   iXBRL EX-FILING FEES 32230
9 GRAPHIC g16145g00a26.jpg GRAPHIC 63475
10 GRAPHIC g16145g1211005513261.jpg GRAPHIC 2675
  Complete submission text file 0001193125-25-314755.txt   1209375

Data Files

Seq Description Document Type Size
23 EXTRACTED XBRL INSTANCE DOCUMENT d16145dexfilingfees_htm.xml XML 13720
Mailing Address 177 E COLORADO BLVD SUITE 700 PASADENA CA 91105
Business Address 177 E COLORADO BLVD SUITE 700 PASADENA CA 91105 626-696-4702
ARROWHEAD PHARMACEUTICALS, INC. (Filer) CIK: 0000879407 (see all company filings)

EIN.: 460408024 | State of Incorp.: DE | Fiscal Year End: 0930
Type: S-3ASR | Act: 33 | File No.: 333-292061 | Film No.: 251563376
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)